Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Planned sale President and CEO sold 147,000 shares at $12.00 ($1,764,000)
  2. 4 Shares withheld for taxes COO and SVP, Compliance gave up 3,177 shares (to pay taxes)
  3. 4 Grant or award CFO and Treasurer acquired 85,130 shares (grant or award)
  4. 4 Open-market buy Director bought 6,400 shares at $7.91 ($50,624)
  5. 4 Open-market buy Director bought 12,500 shares at $8.01 ($100,125)
  6. 4 Open-market buy Director bought 12,500 shares at $8.01 ($100,125)
  7. 4 Shares withheld for taxes COO and SVP, Compliance gave up 20,362 shares (to pay taxes)
  8. 4 Option exercise Director acquired 30,000 shares (option exercise)
  9. 4 Planned sale President and CEO sold 21,000 shares at $15.16 ($318,360)
  10. 4 Open-market sale COO and SVP, Compliance sold 10,096 shares at $15.63 ($157,800)
  11. 4 Shares withheld for taxes President and CEO gave up 85,951 shares (to pay taxes)
  12. 4 Open-market buy Director bought 14,000 shares at an average $15.53 ($217,420)
  13. 4 Shares withheld for taxes President and CEO gave up 54,858 shares (to pay taxes)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes COO and SVP, Compliance gave up 8,161 shares (to pay taxes)
  16. 4 Shares withheld for taxes President and CEO gave up 24,793 shares (to pay taxes)
  17. 4 Shares withheld for taxes CFO and Treasurer gave up 6,479 shares (to pay taxes)
  18. 4 Planned sale President and CEO sold 21,000 shares at $16.08 ($337,680)
  19. 4 Grant or award Director acquired 10,690 shares (grant or award)
  20. 4 Grant or award COO and SVP, Compliance acquired 91,631 shares (grant or award)

Page 1 of 19 · 362 filings